Cladribine Analogues via O6-(Benzotriazolyl) Derivatives of Guanine Nucleosides

Molecules

Sakilam Satishkumar¹  Prasanna K. Vuram¹  Siva Subrahmanyam Relangi³  Venkateshwarlu Gurram³  Hong Zhou²  Robert J. Kreitman²  Michelle M. Martínez Montemayor⁴  Lijia Yang¹  Muralidharan Kaliyaperumal³  Somesh Sharma³  Narender Pottabathini³  Mahesh K. Lakshman¹ 

[1] Department of Chemistry, The City College and The City University of New York, 160 Convent Avenue, New York, NY 10031, USA; E-Mails:;Clinical Immunotherapy Section, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Bethesda, MD 20892, USA; E-Mails:;Discovery and Analytical Services, GVK Biosciences Pvt. Ltd., 28A IDA Nacharam, Hyderabad 500076, India; E-Mails:;Department of Biochemistry, Universidad Central del Caribe-School of Medicine, P. O. Box 60327, Bayamón, PR 00960, USA; E-Mail:

关键词: cladribine;    nucleoside;    guanosine;    benzotriazole;    (benzotriazol-1yl-oxy)-tris(dimethylamino)phosphonium hexafluorophosphate;    BOP;   

DOI  :  10.3390/molecules201018437

来源: mdpi

【 摘 要 】

Cladribine, 2-chloro-2′-deoxyadenosine, is a highly efficacious, clinically used nucleoside for the treatment of hairy cell leukemia. It is also being evaluated against other lymphoid malignancies and has been a molecule of interest for well over half a century. In continuation of our interest in the amide bond-activation in purine nucleosides via the use of (benzotriazol-1yl-oxy)tris(dimethylamino)phosphonium hexafluorophosphate, we have evaluated the use of O⁶-(benzotriazol-1-yl)-2′-deoxyguanosine as a potential precursor to cladribine and its analogues. These compounds, after appropriate deprotection, were assessed for their biological activities, and the data are presented herein. Against hairy cell leukemia (HCL), T-cell lymphoma (TCL) and chronic lymphocytic leukemia (CLL), cladribine was the most active against all. The bromo analogue of cladribine showed comparable activity to the ribose analogue of cladribine against HCL, but was more active against TCL and CLL. The bromo ribose analogue of cladribine showed activity, but was the least active among the C6-NH₂-containing compounds. Substitution with alkyl groups at the exocyclic amino group appears detrimental to activity, and only the C6 piperidinyl cladribine analogue demonstrated any activity. Against adenocarcinoma MDA-MB-231 cells, cladribine and its ribose analogue were most active.

【 授权许可】

CC BY   
© 2015 by the authors; licensee MDPI, Basel, Switzerland.